Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: San Francisco-Oakland-Fremont, CA MSA — October 2026
Bay Area biostats pay surges while regulatory affairs cools.
Metro Biostatistician pay climbed to $164,500 against a flat $131,958 national median, even as Regulatory Affairs Specialist pay slipped to $118,191 locally.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- SF-San Mateo unemployment rate: 4.0% — Down from 4.1% in August 2026
- Biostatistician pay, metro: $164,500 — vs $131,958 national, significant local gain
- Regulatory Affairs Specialist pay, metro: $118,191 — Down moderately vs national $103,780, also down
- Bay Area tech job cuts disclosed: 1,196 — September 2026, Workforce Wonkery tracking
Key takeaways
Biostatistics pay is pulling away from the rest of clinical.
Metro Biostatistician pay rose to $164,500, a significant gain versus a flat national median near $132,000, while Clinical Data Manager pay held stable at $147,042. Data-heavy trial roles appear to be commanding a distinct premium in this metro, a signal worth isolating in compensation reviews separate from a general clinical-ops adjustment.
Regulatory affairs pay is cooling just as the national market tightens.
Metro Regulatory Affairs Specialist pay fell to $118,191 even as national commentary flags regulatory talent as among the hardest life sciences roles to fill in 2026. Local softening may reflect a temporary pullback in postings, making this a role to re-price cautiously with that distinction in mind.
CRA pay gains suggest build-vs-outsource math is shifting.
Clinical Research Associate pay rose to a metro median of $102,500, outpacing the $90,065 national figure, consistent with national reporting that experienced CRAs remain the bottleneck in CRO staffing. Organizations weighing in-house clinical operations against CRO contracts should treat this premium as a signal that outsourcing costs are likely rising in parallel.
Office vacancy and layoff disclosures mask a tighter lab-side market.
Bay Area tech companies disclosed 1,196 job cuts in September while metro unemployment fell to 4.0%, suggesting displaced talent is concentrated outside life sciences' specialized roles. Headcount planners should not expect tech-sector layoffs to meaningfully deepen the candidate pool for regulatory, clinical, or scientific positions.
Median advertised pay by role — San Francisco-Oakland-Fremont, CA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $129,152 | $153,850 | $171,863 | Moderate increase | $130,339 |
| Clinical Research Associate | $78,000 | $102,500 | $110,777 | Moderate increase | $90,065 |
| Lab Technician | $47,993 | $56,160 | $60,320 | Stable | $47,840 |
| Regulatory Affairs Specialist | $79,606 | $118,191 | $138,675 | Moderate decline | $103,780 |
| Clinical Data Manager | $109,760 | $147,042 | $163,046 | Stable | $123,653 |
| Biostatistician | $120,850 | $164,500 | $193,381 | Significant increase | $131,958 |
| Validation Engineer | $104,108 | $121,942 | $134,054 | Stable | $106,478 |
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
San Francisco-San Mateo-Redwood City unemployment fell to 4.0% in September from 4.1% in August even as tech companies disclosed plans to eliminate 1,196 Bay Area jobs, a divergence that reflects specialized scientific and technical labor absorbing cuts concentrated elsewhere in the information sector. Office vacancy holding at 26.7% signals continued contraction in traditional corporate footprints, while lab and R&D space demand in the metro remains comparatively resilient given life sciences' distinct real estate and headcount cycle.
What it means
Biostatistician pay climbing to a $164,500 metro median against a national median of $131,958 signals the metro is bidding up a narrow, credential-bound talent pool even as Regulatory Affairs Specialist pay softens locally, a split that suggests employers are reallocating budget toward roles tied directly to trial execution and data integrity ahead of broader pay increases. National quit rates sitting near 1.9% mean specialists who might otherwise be recruited away are staying put, tightening supply for any organization planning to backfill clinical or biostatistics headcount through hiring instead of internal development. Consider reviewing whether current regulatory affairs offers reflect the local pay pullback or still assume last year's premium, since over-pricing a softening role wastes budget that could support biostatistics or CRA retention.
Looking ahead
Worth watching: Research Scientist pay rose to a metro median of $153,850 against $130,339 nationally, a gap that may widen further if Bay Area biotech funding concentration continues favoring well-capitalized firms. Track whether this premium pulls scientific talent away from smaller, cash-constrained organizations in the metro.
Emerging pressure point: Regulatory Affairs Specialist pay has softened locally while national demand for regulatory talent intensifies around EUDAMED and EU AI Act compliance needs. Watch whether metro postings for compliance-fluent regulatory leaders reverse this trend in the next two pay cycles.
Early indicator: Statewide core life sciences employment grew in 2025 for the first time in three years, and September's Bay Area tech layoffs have not yet shown up as increased life sciences applicant volume. Monitor whether Q4 WARN filings produce any crossover talent with regulatory, quality, or bioprocess credentials.
Potential inflection point: Biostatistician pay's significant jump to $164,500 may reflect a handful of high-value postings and warrants confirmation before being read as a durable market shift. Confirm whether the premium persists into November postings before adjusting broader compensation bands for data science and biostatistics functions.
Sources
- California Employment Development Department — SF-San Mateo-Redwood City unemployment fell to 4.0% in September from 4.1% in August
- Workforce Wonkery — Tech companies disclosed plans to eliminate 1,196 Bay Area jobs in September
- Commercial Cafe — San Francisco office vacancy averaged 26.7%
- Biopharma industry survey research — National quit rate sits near 1.9%, limiting experienced talent movement
- Life sciences industry workforce research — Regulatory affairs, clinical operations, CMC and biomanufacturing are hardest roles to fill
- California life sciences industry research — California core life sciences employment grew in 2025 for first time in three years
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.